Skip to content
Search

Latest Stories

Paul Rees MBE is new Chief Executive of National Pharmacy Association

The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is retiring, NPA said in a statement.

"We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement."


Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association of University Teachers, and the , besides being the Head of Communications at the Home Office.

Rees expressed his excitement about joining the NPA team, emphasising their role in supporting independent community pharmacies and serving the entire pharmacy sector. "I look forward to working with Mark during the handover period and with the NPA Board and staff team in the coming years. I'm eager for the opportunity to serve our members who deliver essential patient care and services across communities throughout the UK,” he added.

Rees also stated that working as the Chief Executive of the RCPsych for the last seven years has been an honour and a privilege. "During this time, we have played a key role in pushing mental health to the top of the political agenda; promoted the benefits of psychiatry and helped increase the number of foundation doctors choosing psychiatry as a career."

From journalist to communications and chief executive...

Rees began his career as a journalist at the Times, Sunday Telegraph, and BBC. He later transitioned to communications, co-leading the right-to-roam campaign at the Ramblers Association, which led to the 2000 Countryside and Rights of Way Act.

During his tenure at the National Housing Federation, he successfully removed pre-payment meter tariffs imposed by 'Big Six' energy companies on low-income households, resulting in annual savings of £100 million.

As Director of Communications at the Charities Aid Foundation, he persuaded the Chancellor in 2012 to withdraw the proposed 'charity tax' on large donations. Rees was involved in the Victoria Climbié and Zahid Mubarek public inquiries, leading to the Children Act 2004 through the Climbié inquiry.

He worked directly with Ministers during his stint as Head of Communications at the Home Office. At the Association of University Teachers, he co-led a successful national campaign to safeguard university lecturers' pay and conditions.

As Director of Policy and Engagement at the Royal College of General Practitioners, he played a crucial role in the "Put Patients First: Back General Practice" campaign, which led to increased funding and the commitment of 11 per cent of the NHS budget in England to general practice. The campaign also led to increased funding for general practice in Scotland, Wales, and Northern Ireland.

Rees praised the collaboration with the RCPsych Board, council members, and staff, emphasising their remarkable achievements in shaping external debates, improving standards and care quality, and internally evolving the College into a high-performing, values-driven organisation that promotes equity, diversity, and inclusion.

In response to NHS England's decision to postpone its vaccination schedule until October, the NPA asserted that its members have a legal basis to seek compensation for losses incurred due to the change in the start date of the vaccination service in England. Following legal counsel, the NPA escalated this matter with NHSE, aiming to address the current situation and emphasise the importance of adhering to due process in the future. However, NHSE later decided to begin the vaccination service on September 11.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less